Trials / Completed
CompletedNCT02550756
Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
An Open Label, Ascending Dose Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Centrexion Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm that the local anesthetic applied to subjects with Morton's Neuroma satisfactorily mitigates procedure pain and ensures that post-procedure discomfort or pain will not result in bias or breaking of the blind in the planned Phase 2b study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTNX-4975 |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-11-01
- First posted
- 2015-09-15
- Last updated
- 2015-09-15
Source: ClinicalTrials.gov record NCT02550756. Inclusion in this directory is not an endorsement.